Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

The Telomerase Inhibitor, Imetelstat, Rapidly Reduces Myeloma Cancer Stem Cells (CSCs) in a Phase II Trial

Carol Ann Huff, M.D., Quiju Wang, MS, Ashraf Z. Badros, MD, Richard J. Jones, Anita Reddy, PhD, Kevin Nishimoto, PhD, Monic J. Stuart, MD, MPH, Stephen M Kelsey, MD, William Matsui, MD

Blood (2012) 120 (21): 4898.

https://doi.org/10.1182/blood.V120.21.4898.4898

Published: 2012

Journal Articles

Prolonged Administration of the Telomerase Vaccine GRNVAC1 Is Well Tolerated and Appears to Be Associated with Favorable Outcomes In High-Risk Acute Myeloid Leukemia (AML)

H. Jean Khoury, MD, FACP, Robert H. Collins, Jr, MD, William Blum, MD, Lori Maness, MD, Patrick Stiff, MD, Stephen M. Kelsey, MD, Anita Reddy, PhD, Jennifer A. Smith, PhD, John F. DiPersio, MD, PhD

Blood (2010) 116 (21): 2190.

https://doi.org/10.1182/blood.V116.21.2190.2190

Published: 2010

Journal Articles

Apaf-1 protein deficiency confers resistance to cytochrome c –dependent apoptosis in human leukemic cells

Li Jia, Srinivasa M. Srinivasula, Feng-Ting Liu, Adrian C. Newland, Teresa Fernandes-Alnemri, Emad S. Alnemri, Stephen M. Kelsey

Blood (2001) 98 (2): 414–421.

https://doi.org/10.1182/blood.V98.2.414

Published: 2001

Journal Articles

Subcellular Distribution and Redistribution of Bcl-2 Family Proteins in Human Leukemia Cells Undergoing Apoptosis

Li Jia, Marion G. Macey, Yuzhi Yin, Adrian C. Newland, Stephen M. Kelsey

Blood (1999) 93 (7): 2353–2359.

https://doi.org/10.1182/blood.V93.7.2353

Published: 1999

Journal Articles

Modulation of Idarubicin-Induced Apoptosis in Human Acute Myeloid Leukemia Blasts by All-Trans Retinoic Acid, 1,25(OH) 2 Vitamin D3, and Granulocyte-Macrophage Colony-Stimulating Factor

Nicolas J. Ketley, Paul D. Allen, Stephen M. Kelsey, Adrian C. Newland

Blood (1997) 90 (11): 4578–4587.

https://doi.org/10.1182/blood.V90.11.4578

Published: 1997

NARROW

The Telomerase Inhibitor, Imetelstat, Rapidly Reduces Myeloma Cancer Stem Cells (CSCs) in a Phase II Trial

Prolonged Administration of the Telomerase Vaccine GRNVAC1 Is Well Tolerated and Appears to Be Associated with Favorable Outcomes In High-Risk Acute Myeloid Leukemia (AML)

Apaf-1 protein deficiency confers resistance to cytochrome c –dependent apoptosis in human leukemic cells

Subcellular Distribution and Redistribution of Bcl-2 Family Proteins in Human Leukemia Cells Undergoing Apoptosis

Modulation of Idarubicin-Induced Apoptosis in Human Acute Myeloid Leukemia Blasts by All-Trans Retinoic Acid, 1,25(OH) 2 Vitamin D3, and Granulocyte-Macrophage Colony-Stimulating Factor

Email alerts

ASH Publications

American Society of Hematology

The Telomerase Inhibitor, Imetelstat, Rapidly Reduces Myeloma Cancer Stem Cells (CSCs) in a Phase II Trial

Prolonged Administration of the Telomerase Vaccine GRNVAC1 Is Well Tolerated and Appears to Be Associated with Favorable Outcomes In High-Risk Acute Myeloid Leukemia (AML)

Apaf-1 protein deficiency confers resistance to cytochrome c –dependent apoptosis in human leukemic cells

Subcellular Distribution and Redistribution of Bcl-2 Family Proteins in Human Leukemia Cells Undergoing Apoptosis

Modulation of Idarubicin-Induced Apoptosis in Human Acute Myeloid Leukemia Blasts by All-Trans Retinoic Acid, 1,25(OH) 2 Vitamin D3, and Granulocyte-Macrophage Colony-Stimulating Factor

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only